NOVOZYMES BIOINDUSTRIAL CHINA A/S
CVR 21599042 · Public limited company (A/S) · Active · Low risk
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Public limited company (A/S), founded on , based in Bagsværd. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 1.0bn and a net result of DKK 119.4m. CEO: Lisbet Kragelund.
Bankruptcy risk for NOVOZYMES BIOINDUSTRIAL CHINA A/S
0.0 × the average (1.41%) · higher risk than 6% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 21599042
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (27 years)
- Address
- Krogshøjvej 36
2880 Bagsværd - Municipality
- Gladsaxe
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 729.7m
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 27 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 99.5% |
| Current ratio | 5,154% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 8 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 0 | DKK -1 | DKK 1 |
| Net profit | DKK 119.4m | DKK 394.6m | DKK 261.0m |
| Equity | DKK 1.0bn | DKK 1.3bn | DKK 1.0bn |
| Total assets | DKK 1.0bn | DKK 1.3bn | DKK 1.0bn |
| Short-term debt | DKK 5.0m | DKK 3.4m | – |
| Avg. employees | 0 | – | – |
Latest annual report: Reporting class C, medium-size enterprise · auditor's statement: Auditor's report on audited financial statements · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 154 | ||
| 1 Jan 2024 – 31 Dec 2024 | 169 | ||
| 1 Jan 2023 – 31 Dec 2023 | 173 | ||
| 1 Jan 2022 – 31 Dec 2022 | 159 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 180 | ||
| 1 Jan 2019 – 31 Dec 2019 | 176 | ||
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 149 | ||
| 1 Jan 2015 – 31 Dec 2015 | 151 | ||
| 1 Jan 2014 – 31 Dec 2014 | 153 | ||
| 1 Jan 2013 – 31 Dec 2013 | 182 | ||
| 1 Jan 2012 – 31 Dec 2012 | 156 | ||
| 1 Jan 2011 – 31 Dec 2011 | 152 | ||
| 1 Jan 2010 – 31 Dec 2010 | 149 | ||
| 1 Jan 2009 – 31 Dec 2009 | 151 | ||
| 1 Jan 2008 – 31 Dec 2008 | 148 | ||
| 1 Jan 2007 – 31 Dec 2007 | 148 | ||
| 1 Jan 2006 – 31 Dec 2006 | 155 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Lisbet Kragelund | Current | |
| CEO | Peter Andreas Stakemann | ||
| Board | Mikkel Viltoft | Current | |
| Board | Rainer Chapour Lehmann | Current | |
| Board | Lisbet Kragelund | Current | |
| Board | Kim Madsen | ||
| Board | Peter Andreas Stakemann | ||
| Board | Annemette Heller | ||
| Board | Kurt Anker Nielsen | ||
| Board | Mads Øvlisen | ||
| Board | Ole Falvig Ramsby | ||
| Board | Steen Riisgaard | ||
| Board | Per Artur Fredrik Månsson | ||
| Board | Benny Dalgaard Loft | ||
| Board | Kristian Merser | ||
| Board | Thomas Videbæk | ||
| Board | Peder Holk Nielsen | ||
| Board | Andrew Patrick Fordyce | ||
| Board | Tina Sejersgård Fanø | ||
| Board | Lars Green | ||
| Board | Randi Camilla Kinch Jensen | ||
| Owner (100%) | NOVOZYMES A/S | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | ApS KBUS 38 nr.3117 | Current |
The CEOs' other companies
Lisbet Kragelund – 15 other companies
- AG-NREP Valby A/S Active
- CHR. HANSEN A/S Active
- DANICA PENSION, LIVSFORSIKRINGSAKTIESELSKAB Active
- DANSKE LEASING A/S Active
- DANSKE PRIVATE EQUITY A/S Active
- FLSMIDTH FINANS A/S Active
- FLSMIDTH MINERALS HOLDING ApS Active
- FLSMIDTH REAL ESTATE A/S Opløst
- FLSMIDTH TYSKLAND A/S Fusioneret
- FORSIKRINGSSELSKABET DANICA, SKADEFORSIKRINGSAKTIESELSKAB AF 1999 Fusioneret
- Fuller Technologies Denmark Holding ApS Active
- NOVOZYMES BIOINDUSTRIAL A/S Active
- Novonesis Plant Biosolutions A/S Active
- Novozymes Biopharma DK A/S Opløst
- SLF ROMER XV ApS Active
Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt
- 01-05-24 ApS Bankrupt 17 Mar 2025
- 061746M A/S Bankrupt 3 Oct 2011
- 1 STEP, COPENHAGEN LOGISTIC & DISTRIBUTION ApS Bankrupt 15 Jan 2009
- 1001 WATT ApS Bankrupt 29 Jan 2002
- 123 AF 04.07.2012 ApS Bankrupt 6 Aug 2012
- 1264 ApS Bankrupt 12 Jun 2012
- 1414 EJENDOMSINVEST 10 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST 12 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST ApS Bankrupt 19 Dec 2014
- 1414 INVEST ApS Bankrupt 22 Dec 2015
- 1WAY2PRINT A/S Bankrupt 24 Jul 2003
- 2 X KJAER DK ApS Bankrupt 18 Dec 2024
- 20220608 ApS Bankrupt 18 Jul 2022
- 23K ApS Bankrupt 17 Jan 2022
- 24237982 A/S Bankrupt 25 Apr 2012
- 2BU EJENDOMME ApS Bankrupt 11 Sep 2013
- 2BU HOLDING ApS Bankrupt 2 Oct 2013
- 2Tal enterprise A/S Bankrupt 28 Apr 2020
- 2V AMAGER SYD ApS Bankrupt 20 Dec 2000
- 3 SIGMA ApS Bankrupt 9 Jun 2005
- 30 08 61 71 ApS Bankrupt 1 Dec 2011
- 31. OKTOBER 2008 ApS Bankrupt 18 Sep 2009
- 32 67 71 93 ApS Bankrupt 16 Nov 2011
- 36087374 ApS Bankrupt 10 Jan 2017
- 365 Service Holding ApS Bankrupt 26 Nov 2020
- 365 Service Partner ApS Bankrupt 26 Nov 2020
- 39701804 ApS Bankrupt 14 Aug 2020
- 39704994 ApS Bankrupt 14 Aug 2020
- 3BH ApS Bankrupt 3 May 2019
- 3XE BYG ApS Bankrupt 11 Aug 2017
Address history (1 moves)
| Krogshøjvej 36, 2880 Bagsværd | |
| c/o Adv. fa. Stakemann, Kronprinsessegade 18, 1306 København K |
Former names
| NOVOZYMES BIOINDUSTRIAL CHINA A/S | – now |
| NOVO NORDISK BIOINDUSTRIAL CHINA A/S | – |
| A/S PSE 17 NR. 1110 | – |
Other companies at the same address
- NOVOZYMES A/S Active
- NOVOZYMES ADENIUM BIOTECH A/S Fusioneret
- NOVOZYMES BIOINDUSTRIAL A/S Active
- NOVOZYMES BIOINDUSTRIAL HOLDING A/S Fusioneret
- NOVOZYMES BIOPOLYMER A/S Fusioneret
- NOVOZYMES BIOPOLYMER HOLDING A/S Fusioneret
- Novozymes Biopharma DK A/S Opløst
- Novozymes Biotechnology ApS Fusioneret
Similar companies in Gladsaxe
- JOHANSEN OG HEIDEN FINANS ApS Bagsværd
- JEBRAKA ApS Bagsværd
- OLIVER ANDERSEN HOLDING A/S Bagsværd
- CORE HOLDING ApS Søborg
- Viking Holdings ApS Søborg
- Kriterion Holding ApS Søborg
- JogS Holding ApS Kongens Lyngby
- Nordkvist Holding ApS Søborg
- Duchan Holding ApS Søborg
- Leafshore Holding ApS Søborg
- Holdingselskabet Andersen & Meldgaard ApS Søborg
- A&H Holding ApS Søborg
Questions and answers about NOVOZYMES BIOINDUSTRIAL CHINA A/S
Has NOVOZYMES BIOINDUSTRIAL CHINA A/S gone bankrupt?
No, NOVOZYMES BIOINDUSTRIAL CHINA A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of NOVOZYMES BIOINDUSTRIAL CHINA A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of NOVOZYMES BIOINDUSTRIAL CHINA A/S?
Lisbet Kragelund is the CEO of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
Who is the auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S?
NOVOZYMES BIOINDUSTRIAL CHINA A/S most recently used EY Godkendt Revisionspartnerselskab.
When was NOVOZYMES BIOINDUSTRIAL CHINA A/S founded?
NOVOZYMES BIOINDUSTRIAL CHINA A/S was founded on 1 January 1999.
What is the equity of NOVOZYMES BIOINDUSTRIAL CHINA A/S?
Equity was DKK 1.0bn according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.